Cargando…
The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)
BACKGROUND: Recent genome-wide association studies have identified multiple loci that are associated with an increased risk of developing coronary artery disease (CAD). The impact of these loci on the disease severity and prognosis of ischemic heart failure due to CAD is currently unknown. METHODS:...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412120/ https://www.ncbi.nlm.nih.gov/pubmed/25528061 http://dx.doi.org/10.1186/s12881-014-0140-3 |
_version_ | 1782368610086289408 |
---|---|
author | Haver, Vincent G Verweij, Niek Kjekshus, John Fox, Jayne C Wedel, Hans Wikstrand, John van Gilst, Wiek H de Boer, Rudolf A van Veldhuisen, Dirk J van der Harst, Pim |
author_facet | Haver, Vincent G Verweij, Niek Kjekshus, John Fox, Jayne C Wedel, Hans Wikstrand, John van Gilst, Wiek H de Boer, Rudolf A van Veldhuisen, Dirk J van der Harst, Pim |
author_sort | Haver, Vincent G |
collection | PubMed |
description | BACKGROUND: Recent genome-wide association studies have identified multiple loci that are associated with an increased risk of developing coronary artery disease (CAD). The impact of these loci on the disease severity and prognosis of ischemic heart failure due to CAD is currently unknown. METHODS: We undertook association analysis of 7 single nucleotide polymorphism (rs599839, rs17465637, rs2972147, rs6922269, rs1333049, rs501120, and rs17228212) at 7 well established CAD risk loci (1p13.3, 1q41, 2q36.3, 6q25.1, 9p21.3, 10q11.21, and 15q22.33, respectively) in 3,320 subjects diagnosed with systolic heart failure of ischemic aetiology and participating in the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA) trial. The primary outcome was the composite of time to first event of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, secondary outcomes included mortality and hospitalization due to worsening heart failure. RESULTS: None of the 7 loci were significantly associated with the primary composite endpoint of the CORONA trial (death from cardiovascular cases, nonfatal myocardial infarction, and nonfatal stroke). However, the 1p13.3 locus (rs599839) showed evidence for association with all-cause mortality (after adjustment for covariates; HR 0.74, 95%CI [0.61 to 0.90]; P = 0.0025) and we confirmed the 1p13.3 locus (rs599839) to be associated with lipid parameters (total cholesterol (P = 1.1x10(−4)), low-density lipoprotein levels (P = 3.5 × 10(−7)) and apolipoprotein B (P = 2.2 × 10(−10))). CONCLUSION: Genetic variants strongly associated with CAD risk are not associated with the severity and outcome of ischemic heart failure. The observed association of the 1p13.3 locus with all-cause mortality requires confirmation in further studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-014-0140-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4412120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44121202015-04-29 The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA) Haver, Vincent G Verweij, Niek Kjekshus, John Fox, Jayne C Wedel, Hans Wikstrand, John van Gilst, Wiek H de Boer, Rudolf A van Veldhuisen, Dirk J van der Harst, Pim BMC Med Genet Research Article BACKGROUND: Recent genome-wide association studies have identified multiple loci that are associated with an increased risk of developing coronary artery disease (CAD). The impact of these loci on the disease severity and prognosis of ischemic heart failure due to CAD is currently unknown. METHODS: We undertook association analysis of 7 single nucleotide polymorphism (rs599839, rs17465637, rs2972147, rs6922269, rs1333049, rs501120, and rs17228212) at 7 well established CAD risk loci (1p13.3, 1q41, 2q36.3, 6q25.1, 9p21.3, 10q11.21, and 15q22.33, respectively) in 3,320 subjects diagnosed with systolic heart failure of ischemic aetiology and participating in the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA) trial. The primary outcome was the composite of time to first event of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, secondary outcomes included mortality and hospitalization due to worsening heart failure. RESULTS: None of the 7 loci were significantly associated with the primary composite endpoint of the CORONA trial (death from cardiovascular cases, nonfatal myocardial infarction, and nonfatal stroke). However, the 1p13.3 locus (rs599839) showed evidence for association with all-cause mortality (after adjustment for covariates; HR 0.74, 95%CI [0.61 to 0.90]; P = 0.0025) and we confirmed the 1p13.3 locus (rs599839) to be associated with lipid parameters (total cholesterol (P = 1.1x10(−4)), low-density lipoprotein levels (P = 3.5 × 10(−7)) and apolipoprotein B (P = 2.2 × 10(−10))). CONCLUSION: Genetic variants strongly associated with CAD risk are not associated with the severity and outcome of ischemic heart failure. The observed association of the 1p13.3 locus with all-cause mortality requires confirmation in further studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-014-0140-3) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-21 /pmc/articles/PMC4412120/ /pubmed/25528061 http://dx.doi.org/10.1186/s12881-014-0140-3 Text en © Haver et al.; licensee BioMed Central. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Haver, Vincent G Verweij, Niek Kjekshus, John Fox, Jayne C Wedel, Hans Wikstrand, John van Gilst, Wiek H de Boer, Rudolf A van Veldhuisen, Dirk J van der Harst, Pim The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA) |
title | The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA) |
title_full | The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA) |
title_fullStr | The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA) |
title_full_unstemmed | The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA) |
title_short | The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA) |
title_sort | impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the controlled rosuvastatin multinational trial in heart failure (corona) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412120/ https://www.ncbi.nlm.nih.gov/pubmed/25528061 http://dx.doi.org/10.1186/s12881-014-0140-3 |
work_keys_str_mv | AT havervincentg theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT verweijniek theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT kjekshusjohn theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT foxjaynec theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT wedelhans theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT wikstrandjohn theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT vangilstwiekh theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT deboerrudolfa theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT vanveldhuisendirkj theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT vanderharstpim theimpactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT havervincentg impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT verweijniek impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT kjekshusjohn impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT foxjaynec impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT wedelhans impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT wikstrandjohn impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT vangilstwiekh impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT deboerrudolfa impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT vanveldhuisendirkj impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona AT vanderharstpim impactofcoronaryarterydiseaserisklocionischemicheartfailureseverityandprognosisassociationanalysisinthecontrolledrosuvastatinmultinationaltrialinheartfailurecorona |